On Friday, Quince Therapeutics Inc (NASDAQ: QNCX) was -4.94% drop from the session before settling in for the closing price of $1.62. A 52-week range for QNCX has been $0.51 – $1.79.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
With a float of $32.08 million, this company’s outstanding shares have now reached $42.97 million.
The firm has a total of 32 workers. Let’s measure their productivity. In terms of profitability, gross margin is -977.78%, operating margin of -81811.11%, and the pretax margin is -147236.11%.
Quince Therapeutics Inc (QNCX) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Quince Therapeutics Inc stocks. The insider ownership of Quince Therapeutics Inc is 25.87%, while institutional ownership is 14.00%. The most recent insider transaction that took place on Aug 30 ’24, was worth 53,900. In this transaction CEO AND CHIEF MEDICAL OFFICER of this company bought 77,000 shares at a rate of $0.70, taking the stock ownership to the 843,941 shares. Before that another transaction happened on Aug 29 ’24, when Company’s CEO AND CHIEF MEDICAL OFFICER bought 77,500 for $0.69, making the entire transaction worth $53,475. This insider now owns 766,941 shares in total.
Quince Therapeutics Inc (QNCX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
For the long-term projections, market analysts anticipate that the company’s EPS will surge by 18.30% during the next five years compared to -12.64% drop over the previous five years of trading.
Quince Therapeutics Inc (NASDAQ: QNCX) Trading Performance Indicators
You can see what Quince Therapeutics Inc (QNCX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.27, a number that is poised to hit -0.15 in the next quarter
Technical Analysis of Quince Therapeutics Inc (QNCX)
Analysing the last 5-days average volume posted by the [Quince Therapeutics Inc, QNCX], we can find that recorded value of 3.23 million was better than the volume posted last year of 0.22 million. As of the previous 9 days, the stock’s Stochastic %D was 70.75%. Additionally, its Average True Range was 0.18.
During the past 100 days, Quince Therapeutics Inc’s (QNCX) raw stochastic average was set at 80.44%, which indicates a significant increase from 76.79% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 177.23% in the past 14 days, which was higher than the 102.57% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8222, while its 200-day Moving Average is $0.9294. Now, the first resistance to watch is $1.7000. This is followed by the second major resistance level at $1.8600. The third major resistance level sits at $2.0000. If the price goes on to break the first support level at $1.4000, it is likely to go to the next support level at $1.2600. Should the price break the second support level, the third support level stands at $1.1000.
Quince Therapeutics Inc (NASDAQ: QNCX) Key Stats
There are 43,277K outstanding shares of the company, which has a market capitalization of 63.36 million. As of now, sales total 0 K while income totals -31,390 K. Its latest quarter income was 0 K while its last quarter net income were -27,730 K.
